ARTIVION INC (AORT)
US2289031005 - Common Stock
Artivion Reports Third Quarter 2024 Financial Results
Third Quarter Highlights: Achieved revenue of $95.8 million in the third quarter of 2024 versus $87.9 million in the third quarter of 2023, an increase of 9%...
Artivion to Participate in Upcoming Investor Conferences
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024...
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its AMDS DARTS...
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024
AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artivion (NYSE:AORT) just reported results for the second quarter of 2024.Artiv...
Artivion Reports Second Quarter 2024 Financial Results
Second Quarter Highlights: Achieved revenue of $98.0 million in the second quarter of 2024 versus $89.3 million in the second quarter of 2023, an increase of...
Artivion to Participate in Upcoming Investor Conferences
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024...
3 Earnings All-Stars With More Room to Run
Travelers, Seagate Technology and Artivion are top earnings outperformers poised for further growth and significant returns.
Artivion Amends Agreements with Endospan
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its...
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artivion (NYSE:AORT) just reported results for the first quarter of 2024.Artivi...
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024
AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Artivion Reports First Quarter 2024 Financial Results
First Quarter Highlights: Achieved revenue of $97.4 million in the first quarter of 2024 versus $83.2 million in the first quarter of 2023, an increase of 17%...
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new...
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024...
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...
Artivion files automatic mixed securities shelf (NYSE:AORT)
Artivion (AORT) files a prospectus for mixed shelf offering.
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
Fourth Quarter and Recent Business Highlights: Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of...
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and...
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of...
Artivion Obtains $350 Million in Senior Secured Credit Facilities
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the closing of a...
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease today announced the appointment of Lance...